Clari Vest Asset Management LLC Verastem, Inc. Transaction History

Clari Vest Asset Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$0.92 - $11.16 $70,774 - $858,527	76,929 Added 8.73%	958,324 $815,000
Q2 2022 Aug 12, 2022	BUY	$1.02 - $1.83 $104,448 - $187,392	102,400 Added 13.15%	881,395 $1.02 Million
Q1 2022 May 04, 2022	SELL	$1.06 - $2.1 $219,352 - $434,565	-206,936 Reduced 20.99%	778,995 $1.1 Million
Q4 2021 Feb 14, 2022	SELL	$2.05 - $3.2 $155,074 - $242,067	-75,646 Reduced 7.13%	985,931 $2.02 Million
Q3 2021 Nov 08, 2021	SELL	$2.54 - $4.07 $104,919 - $168,119	-41,307 Reduced 3.75%	1,061,577 $3.27 Million
Q2 2021 Aug 09, 2021	BUY	$2.57 - $4.85 $2.83 Million - $5.35 Million	1,102,884 New	1,102,884 $4.49 Million
Q3 2018 Nov 07, 2018	SELL	$6.86 - $9.97 $445,214 - $647,053	-64,900 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$2.88 - $8.67 $160,704 - $483,786	-55,800 Reduced 46.23%	64,900 $447,000
Q1 2018 May 08, 2018	BUY	$2.92 - $3.81 $90,520 - $118,110	31,000 Added 34.56%	120,700 $360,000
Q3 2017 Nov 07, 2017	BUY	$3.01 - $5.41 $269,997 - $485,277	89,700	89,700 $421,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.09B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.